# Evaluation of Pupil Dilation Speed With the MAP Dispenser

> **NCT04907474** · PHASE4 · COMPLETED · sponsor: **Eyenovia Inc.** · enrollment: 61 (actual)

## Conditions studied

- Mydriasis

## Interventions

- **DRUG:** tropicamide-phenylephrine fixed combination ophthalmic solution

## Key facts

- **NCT ID:** NCT04907474
- **Lead sponsor:** Eyenovia Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-24
- **Primary completion:** 2021-06-03
- **Final completion:** 2021-06-03
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04907474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04907474, "Evaluation of Pupil Dilation Speed With the MAP Dispenser". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04907474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*